Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05140876 · ClinicalTrials.gov registry record · NA
Supporting Treatment Adherence for Resilience and Thriving (START)
A NA study, sponsored by Florida International University.
- Completed
- Registry status
- NA
- Development phase
- 286
- Enrollment target
NCT05140876: Completed NA study, sponsored by Florida International University.
NCT05140876 is a NA study that has completed, run by Florida International University. The registered enrollment target is 286 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05140876, a NA study, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 286 participants
- Enrollment target
Study Summary
This Phase II randomized controlled trial is testing the efficacy of a cell phone application called START for helping men who use stimulants like methamphetamine to get the most out of their HIV treatment.
Primary Outcome
Proportion of participants with a viral load \> 300 copies/mL from dried blood spot samples
Interventions
- BEHAVIORAL START mHealth Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 286 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT05140876 record still lists
NCT05140876 is an interventional study that assigns participants to a tested intervention. The registered 286 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which START mHealth Intervention is the first listed.
NCT05140876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05140876 about?
NCT05140876 is a clinical study titled "Supporting Treatment Adherence for Resilience and Thriving (START)". This Phase II randomized controlled trial is testing the efficacy of a cell phone application called START for helping men who use stimulants like methamphetamine to get the most out of their HIV treatment.
What is the current status of trial NCT05140876?
This trial is currently completed. It is a NA study. The enrollment target is 286 participants. The study started on 2022-06-15. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT05140876?
The interventions under investigation include: START mHealth Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05140876?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05140876's enrollment target sits among peer trials
286 377th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04781140 · 286 participants · Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- NCT04936529 · 286 participants · Phase 2
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- NCT05183646 · 286 participants · Phase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- NCT05506878 · 286 participants · NA
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI